MedSciences Capital http://www.medsciencescapital.com MedSciences Capital Wed, 25 Jan 2012 08:59:16 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates http://www.medsciencescapital.com/news/prosensa-raises-e23-million-in-new-equity-financing-led-by-new-enterprise-associates/ http://www.medsciencescapital.com/news/prosensa-raises-e23-million-in-new-equity-financing-led-by-new-enterprise-associates/#comments Wed, 25 Jan 2012 08:57:36 +0000 piet http://www.medsciencescapital.com/?p=1128 http://www.medsciencescapital.com/news/prosensa-raises-e23-million-in-new-equity-financing-led-by-new-enterprise-associates/feed/ 0 Pronota announces EUR 3.7 million Series C financing; management and board changes http://www.medsciencescapital.com/news/pronota-announces-eur-3-7-million-series-c-financing-management-and-board-changes/ http://www.medsciencescapital.com/news/pronota-announces-eur-3-7-million-series-c-financing-management-and-board-changes/#comments Fri, 20 Jan 2012 15:24:59 +0000 piet http://www.medsciencescapital.com/?p=1118 http://www.medsciencescapital.com/news/pronota-announces-eur-3-7-million-series-c-financing-management-and-board-changes/feed/ 0 Prosensa to Receive $1.5m from Charley’s Fund for Skipping of Exon 52 in Duchenne Muscular Dystrophy Patients http://www.medsciencescapital.com/news/prosensa-to-receive-1-5m-from-charley%e2%80%99s-fund-for-skipping-of/ http://www.medsciencescapital.com/news/prosensa-to-receive-1-5m-from-charley%e2%80%99s-fund-for-skipping-of/#comments Thu, 01 Dec 2011 09:06:38 +0000 piet http://www.medsciencescapital.com/?p=1108 http://www.medsciencescapital.com/news/prosensa-to-receive-1-5m-from-charley%e2%80%99s-fund-for-skipping-of/feed/ 0 Prosensa Updates on Patent Position http://www.medsciencescapital.com/news/prosensa-updates-on-patent-position/ http://www.medsciencescapital.com/news/prosensa-updates-on-patent-position/#comments Fri, 18 Nov 2011 15:53:49 +0000 piet http://www.medsciencescapital.com/?p=1079 http://www.medsciencescapital.com/news/prosensa-updates-on-patent-position/feed/ 0 Mucosis Announces New Scientific Advisory Board http://www.medsciencescapital.com/news/mucosis-announces-new-scientific-advisory-board/ http://www.medsciencescapital.com/news/mucosis-announces-new-scientific-advisory-board/#comments Tue, 15 Nov 2011 10:15:01 +0000 piet http://www.medsciencescapital.com/?p=1075 http://www.medsciencescapital.com/news/mucosis-announces-new-scientific-advisory-board/feed/ 0 Prosensa named Most Innovative European Biotech SME http://www.medsciencescapital.com/news/prosensa-named-most-innovative-european-biotech-sme/ http://www.medsciencescapital.com/news/prosensa-named-most-innovative-european-biotech-sme/#comments Tue, 08 Nov 2011 16:53:17 +0000 piet http://www.medsciencescapital.com/?p=1069 http://www.medsciencescapital.com/news/prosensa-named-most-innovative-european-biotech-sme/feed/ 0 Prosensa Awarded up to €5m Innovation Credit from Dutch Government for research in Myotonic Dystrophy http://www.medsciencescapital.com/news/prosensa-awarded-up-to-e5m-innovation-credit-from-dutch-government-for-research-in-myotonic-dystrophy/ http://www.medsciencescapital.com/news/prosensa-awarded-up-to-e5m-innovation-credit-from-dutch-government-for-research-in-myotonic-dystrophy/#comments Tue, 25 Oct 2011 09:24:37 +0000 piet http://www.medsciencescapital.com/?p=1053 http://www.medsciencescapital.com/news/prosensa-awarded-up-to-e5m-innovation-credit-from-dutch-government-for-research-in-myotonic-dystrophy/feed/ 0 Prosensa Advances Three Exon Skipping Candidates for Duchenne Muscular Dystrophy into the Next Development Stage http://www.medsciencescapital.com/news/prosensa-advances-three-exon-skipping-candidates-for-duchenne-muscular-dystrophy-into-the-next-development-stage/ http://www.medsciencescapital.com/news/prosensa-advances-three-exon-skipping-candidates-for-duchenne-muscular-dystrophy-into-the-next-development-stage/#comments Tue, 13 Sep 2011 08:11:05 +0000 piet http://www.medsciencescapital.com/?p=1045 http://www.medsciencescapital.com/news/prosensa-advances-three-exon-skipping-candidates-for-duchenne-muscular-dystrophy-into-the-next-development-stage/feed/ 0 Mucosis appoints Thomas Johnston as Chief Business Officer http://www.medsciencescapital.com/news/mucosis-appoints-thomas-johnston-as-chief-business-officer/ http://www.medsciencescapital.com/news/mucosis-appoints-thomas-johnston-as-chief-business-officer/#comments Tue, 17 May 2011 09:29:56 +0000 piet http://www.medsciencescapital.com/?p=1011 http://www.medsciencescapital.com/news/mucosis-appoints-thomas-johnston-as-chief-business-officer/feed/ 0 Results of Prosensa’s Extended Phase I/II Exon-skipping Trial in Duchenne Muscular Dystrophy Published in the New England Journal of Medicine http://www.medsciencescapital.com/news/results-of-prosensa%e2%80%99s-extended-phase-iii-exon-skipping-trial-in-duchenne-muscular-dystrophy-published-in-the-new-england-journal-of-medicine/ http://www.medsciencescapital.com/news/results-of-prosensa%e2%80%99s-extended-phase-iii-exon-skipping-trial-in-duchenne-muscular-dystrophy-published-in-the-new-england-journal-of-medicine/#comments Thu, 24 Mar 2011 08:57:17 +0000 piet http://www.medsciencescapital.com/?p=996 http://www.medsciencescapital.com/news/results-of-prosensa%e2%80%99s-extended-phase-iii-exon-skipping-trial-in-duchenne-muscular-dystrophy-published-in-the-new-england-journal-of-medicine/feed/ 0